Autopsy report · NCT00957788
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
Cause of deathNo reason given
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 4 years 4 months before it stopped.
- 8 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- NeuroSystec Corporation
- Sponsor type
- Industry
- Conditions
- Tinnitus
- Interventions
- NST-001
- Participants
- 8
- Sites
- 2
- Countries
- Belgium, France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.